Detalhe da pesquisa
1.
Machine learning reveals the contribution of lipoproteins to liver triglyceride content and inflammation.
J Clin Endocrinol Metab;
2024 Jun 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38833012
2.
The first MASH drug therapy on the horizon: Current perspectives of resmetirom.
Liver Int;
2024 Apr 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-38578141
3.
3D culture models to study pathophysiology of steatotic liver disease.
Atherosclerosis;
: 117544, 2024 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38677899
4.
The contribution of genetics and epigenetics to MAFLD susceptibility.
Hepatol Int;
2024 Apr 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-38662298
5.
Poor accuracy and sustainability of the first-step FIB4 EASL pathway for stratifying steatotic liver disease risk in the general population.
Aliment Pharmacol Ther;
59(11): 1402-1412, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38497224
6.
ANGPTL3 Downregulation Increases Intracellular Lipids by Reducing Energy Utilization.
Arterioscler Thromb Vasc Biol;
44(5): 1086-1097, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38385290
7.
Risk of major adverse liver outcomes among first-degree relatives of individuals with MASLD.
Liver Int;
44(5): 1253-1264, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38385564
8.
Mitochondrial amidoxime-reducing component 1 p.Ala165Thr increases protein degradation mediated by the proteasome.
Liver Int;
44(5): 1219-1232, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38375985
9.
Exploring the impact of the PNPLA3 I148M variant on primary human hepatic stellate cells using 3D extracellular matrix models.
J Hepatol;
80(6): 941-956, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38365182
10.
Partitioned polygenic risk scores identify distinct types of metabolic dysfunction-associated steatotic liver disease.
Res Sq;
2024 Feb 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-38405802
11.
Author Correction: Interaction between estrogen receptor-α and PNPLA3 p.I148M variant drives fatty liver disease susceptibility in women.
Nat Med;
30(4): 1212, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38267549
12.
Performance of non-invasive tests for liver fibrosis resolution after bariatric surgery.
Metabolism;
153: 155790, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38219973
13.
Corrigendum to "SIRT5 rs12216101 T>G variant is associated with liver damage and mitochondrial dysfunction in patients with non-alcoholic fatty liver disease" [J Hepatol 80 (2024) 10-19].
J Hepatol;
80(2): 378, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38182533
14.
IL32 downregulation lowers triglycerides and type I collagen in di-lineage human primary liver organoids.
Cell Rep Med;
5(1): 101352, 2024 01 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-38232700
15.
Predictors of controlled attenuation parameter in metabolic dysfunction.
United European Gastroenterol J;
12(3): 364-373, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38141028
16.
Knockout of STE20-type kinase TAOK3 does not attenuate diet-induced NAFLD development in mice.
Mol Med;
29(1): 138, 2023 Oct 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-37864157
17.
Generation and validation of a classification model to diagnose familial hypercholesterolaemia in adults.
Atherosclerosis;
383: 117314, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37813054
18.
Measuring the impact of the updated Steatotic liver disease nomenclature and definition.
Liver Int;
43(11): 2340-2342, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37846803
19.
Endocrine aspects of metabolic dysfunction-associated steatotic liver disease (MASLD): Beyond insulin resistance.
J Hepatol;
79(6): 1524-1541, 2023 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37730124
20.
Usefulness of PNPLA3 variant for predicting hepatic events in steatotic liver disease: a matter of ethnicity or baseline risk?
Liver Int;
43(10): 2052-2054, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37718719